The weekly litigation news digest is live. Subscribe now

IP Verse

Use Of Eicosapentaenoic Acid Ethyl Ester For Treating Hypertriglyceridemia - EP2596786

The patent EP2596786 was granted to Amarin Pharmaceuticals Ireland on Nov 27, 2019. The application was filed on Feb 9, 2010 under application number EP13156122A. The patent is currently recorded with a legal status of "Revoked".

EP2596786

AMARIN PHARMACEUTICALS IRELAND
Application Number
EP13156122A
Filing Date
Feb 9, 2010
Status
Revoked
Oct 7, 2022
Publication Date
Nov 27, 2019
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions (2)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status
HOFFMANN EITLEAug 26, 2020HOFFMANN EITLEADMISSIBLE
ELKINGTON AND FIFEAug 25, 2020ELKINGTON AND FIFEADMISSIBLE

Patent Citations (7) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication Number
OPPOSITIONEP0610506
OPPOSITIONEP1790338
OPPOSITIONEP1790339
OPPOSITIONEP2395991
OPPOSITIONUS2008200547
OPPOSITIONWO2010028067
OPPOSITIONWO2010093634

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents